Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aurix
- Development stage
- Unknown
- Lead developer
- Nuo Therapeutics
- Modality
- Autologous CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Patient-derived iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies, Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Aurix is an autologous platelet-rich plasma (PRP) gel used as a topical wound treatment. It is created from a patient’s own blood at the point of care and applied directly to chronic non-healing wounds such as diabetic foot ulcers, venous leg ulcers, and pressure injuries. The mechanism of action involves concentrating and activating the patient's platelets to release growth factors that stimulate tissue repair and accelerate healing. By utilizing autologous PRP, Aurix reduces the risk of immune rejection or allergic reaction. Clinical evidence supports its efficacy in improving healing rates for chronic ulcerations compared to standard care[6].
- Brand names
- Aurix
- Other names
- Aurix gelbiodynamic hematogelplatelet-rich plasma gel
02
Targets
PDGFRA (Platelet-derived growth factor receptor alpha)TGFBR (TGF-beta receptor)
Beyond the preview
Go deeper on Aurix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aurix.